Ambroxol

Description

Ambroxol induces activation of the surfactant system by acting directly on the type II pneumocytes of the alveoles and the Clara cells in the region of the small airways. It promotes the formation and outward transfer of surface-active material in the alveolar and bronchial region of the foetal and adult lungs.

Medicine classification

ATC Code
Title
Class
Ambroxol
R Respiratory system → R05 Cough and cold preparations → R05C Expectorants, excl. combinations with cough suppressants → R05CB Mucolytics

Medicines

Drug
Countries

Lithuania

Austria

Austria

Austria Lithuania

Hong Kong

Lithuania

Lithuania

Lithuania

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong Singapore

Spain

Hong Kong

Hong Kong Singapore

Lithuania

Lithuania

Spain

Spain

Hong Kong

Lithuania

Cyprus

Hong Kong

Lithuania

Cyprus

Lithuania

Hong Kong

Cyprus

Cyprus Hong Kong

Spain

Hong Kong

Hong Kong

Spain

Austria Netherlands

Hong Kong

Cyprus

Singapore

Hong Kong

Austria Spain

Austria Cyprus Hong Kong Singapore

Spain

France

Hong Kong

Singapore

Singapore

Hong Kong Singapore

France

Hong Kong

Hong Kong

Other medications with this active ingredient in combination: MUCOSPAS

Product monographs

Monograph
Type
Country

2D Molecule Structure

2D representation of molecule

Unique Ingredient Identifier (UNII)

200168S0CL - AMBROXOL

CAS Registry Number

18683-91-5 - ambroxol

SNOMED-CT

698024002 - Ambroxol (substance)